BRMS1 and cutaneous melanoma: Using tissue microarray technology and immunohistochemistry, Li et al [50] demonstrated in cutaneous melanoma that via suppression of NF-κB activity as well as IL-6, BRMS1 overexpression inhibited endothelial cell growth and tube formation ability.